Clinical Trial Update: Sirolimus in the Treatment of Refractory/Relapsed wAIHA [NA]

View source ↗

Summary

Sirolimus is being studied for refractory/relapsed warm autoimmune hemolytic anemia, and the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Warm Autoimmune Hemolytic Anemia

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Warm Autoimmune Hemolytic Anemia | NA | Status: RECRUITING